Skip to main content
. 2015 Feb 27;10(2):e0118228. doi: 10.1371/journal.pone.0118228

Fig 2. Virologic response at Week 96, by randomised arm, study population and screening strata.

Fig 2

RAL = lopinavir/ritonavir+raltegravir Control = lopinavir/ritonavir+2/3 nucleoside/nucleotide reverse transcriptase inhibitors. *grey circle = screening plasma viral load strata, P interaction = 0.81, bars are 95%confidence intervals (CI).